A Study to Investigate the Safety and Immunogenicity of Monovalent Omicron LP.8.1-Adapted BNT162b2 COVID-19 Vaccine in Adults ≥ 65 Years of Age and High-Risk Adults 18-64 Years of Age (Preliminary Results)
一项研究旨在调查单价 Omicron LP.8.1 适应性 BNT162b2 COVID-19 疫苗在 ≥ 65 岁成人和 18-64 岁高危成人中的安全性和免疫原性（初步结果）
期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines14040350
Dadhe, Rucha; Gayed, Juleen; Iqbal, Muneeb; Solan, Rohit; Wu, Han; Ma, Hua; Xu, Xia; Mensa, Federico J; Belanger, Todd; Cooper, David; Mogg, Robin; Anderson, Annaliesa S; Türeci, Özlem; Şahin, Uǧur; Allen, Pirada Suphaphiphat; Modjarrad, Kayvon; Gurtman, Alejandra; Lindert, Kelly
